Physician profile
Edwin Heidelberger
NPI 1821070970
$2,991.88
in general payments reported to CMS, 2019-2025
36 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $39.76 · 2021: $13.82 · 2022: $452 · 2023: $682 · 2024: $592 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $415.52 | 2019-2025 | Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $369.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $213.21 | 2022-2025 | Otezla, Repatha, Otezla |
| Abbvie INC. | $205.55 | 2022-2025 | |
| Pfizer INC. | $191.43 | 2019-2025 | |
| Exact Sciences Corporation | $171.57 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $162.68 | 2019-2025 | Jardiance, Mounjaro |
| Gilead Sciences, INC. | $129.43 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $114.71 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.32 | 2019-2024 | Ofev |
| Merck Sharp & Dohme LLC | $96.26 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Edwards Lifesciences Corporation | $77.82 | 2022-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $76.62 | 2021-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $59.08 | 2019-2022 | |
| Astellas Pharma US INC | $55.30 | 2023-2025 | Veozah |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Heidelberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.